p16INK4a Expression, human papillomavirus, and survival in head and neck cancer

Oral Oncology

Volumn 44, Issue 2, 2008, Pages 133-142

  Smith, Elaine M ^a   Wang, Donghong ^a   Kim, Yoonsang ^a   Rubenstein, Linda M ^a   Lee, John H ^b   Haugen, Thomas H ^c   Turek, Lubomir P ^c  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Head and neck cancer survival; HPV; p16INK4a.

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; PROTEIN P16; KI 67 ANTIGEN; TUMOR MARKER; VIRUS DNA;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; CANCER LOCALIZATION; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HEAD AND NECK CANCER; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; RISK FACTOR; SMOKING; VIRUS TYPING; WART VIRUS; DISEASE FREE SURVIVAL; GENE EXPRESSION; GENETICS; HEAD AND NECK TUMOR; HUMAN PAPILLOMAVIRUS TYPE 11; MIDDLE AGED; MORTALITY; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; SQUAMOUS CELL CARCINOMA; STAINING; SURVIVAL; TUMOR RECURRENCE; VIROLOGY; VIRUS INFECTION;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DISEASE-FREE SURVIVAL; DNA, VIRAL; FEMALE; GENE EXPRESSION; HEAD AND NECK NEOPLASMS; HUMAN PAPILLOMAVIRUS 11; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PAPILLOMAVIRUS INFECTIONS; PROPORTIONAL HAZARDS MODELS; STAINING AND LABELING; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 38749121287     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2007.01.010     Document Type: Article

References (36)

1. Smith E.M., Ritchie J.R., Summersgill K.F., Hoffman H.T., Wang D.H., Haugen T.H., et al. Human papillomavirus in oral exfoliated cells and risk of head and neck cancer. J Natl Cancer Inst 96 (2004) 449-455
2. Mork J., Lie A.K., Glattre E., Hallmans G., Jellum E., Koskela P., et al. Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med 344 (2001) 1125-1131
3. Kreimer A.R., Clifford G.M., Boyle P., and Franceschi S. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomark Prev 14 (2005) 467-475
4. Li Y., Nichols M.A., Shay J.W., and Xiong Y. Transcriptional repression of the d-type cyclin-dependent kinase inhibitor p16 by the retinoblastoma susceptibility gene product pRb. Cancer Res 54 (1994) 6078-6082
5. INK4a as a marker of oncogenic human papillomavirus infection in cervical biopsies from a population-based cohort in Costa Rica. Cancer Epidemiol Biomark Prev 13 (2004) 1355-1360
6. Klaes R., Benner A., Friedrich T., Ridder R., Herrington S., Jenkins D., et al. P16 immunohistochemistry improves interobserver agreement in the diagnosis of cervical intraepithelial neoplasia. Am J Surg Pathol 26 (2002) 1389-1399
7. Sano T., Masuda N., Oyama T., and Nakajima T. Overexpression of p16 and p14arf is associated with human papillomavirus infection in cervical squamous cell carcinoma and dysplasia. Pathol Int 52 (2002) 375-383
8. Lowe S.W., and Sherr C.J. Tumor suppression by Ink4a-Arf: progress and puzzles. Curr Opin Gene Dev 13 (2003) 77-83
9. Lang J.C., Tobin E.J., Knobloch T.J., Schuller D.E., Bartynski K.J., Mountain R.E., et al. Frequent mutation of p16 in squamous cell carcinoma of the head and neck. Laryngoscope 108 (1998) 923-928
10. El-Naggar A.K., Lai S., Clayman G., Lee J.-K., Luna M.A., Goedfert H., et al. Methylation, a major mechanism of p16/CDKN2 gene inactivation in head and neck squamous carcinoma. Am J Pathol 151 (1997) 1767-1774
11. Weinberger P.M., Yu Z., Haffty B.G., Kowalski D., Harigopal M., Brandsma J., et al. Molecular classification identifies a subset of human papillomavirus-associated oropharyngeal cancers with favorable prognosis. J Clin Oncol 24 (2006) 736-747
12. Andl T., Kahn T., Pfuhl A., Nicola T., Erber R., Conradt C., et al. Etiological involvement of oncogenic human papillomavirus in tonsillar squamous cell carcinomas lacking retinoblastoma cell cycle control. Cancer Res 58 (1998) 5-13
13. Bova R.J., Quinn D.I., Nankervis J.S., Cole I.E., Sheridan B.F., Jensen M.J., et al. Cyclin d1 and p16 expression predict reduced survival in carcinoma of the anterior tongue. Clin Cancer Res 5 (1999) 2810-2819
14. Klussmann J.P., Gultekin E., Weissenborn S.J., Wieland U., Dries V., Dienes H.P., et al. Expression of p16 protein identifies a distinct entity of tonsillar carcinomas associated with human papillomavirus. Am J Pathol 162 (2003) 747-753
15. Li W., Thompson C.H., O'Brien C.J., McNeil E.B., Scolyer R.A., Cossart Y.E., et al. Human papillomavirus positivity predicts favourable outcome for squamous carcinoma of the tonsil. Int J Cancer 106 (2003) 553-558
16. INK4a and Fhit expression in carcinogenesis and progression of human oral cancer. Int J Oncol 24 (2004) 249-255
17. Emmert-Buck M.R., Bonner R.F., Smith P.D., Chuaqui R.F., Zhuang Z., Goldstein S.R., et al. Laser capture microdissection. Science 274 (1996) 998-1001
18. In: Fleming I.D., Cooper J.S., Henson D.E., Hutter R.V.P., Kennedy B.J., Murphy G.P., et al. (Eds). AJCC cancer staging manual. 5th ed. (1997), Lippincott-Raven, Philadelphia (PA)
19. Summersgill K.F., Smith E.M., Levy B.T., Allen J.M., Haugen T.H., and Turek L.P. Human papillomavirus in the oral cavities of children and adolescents. Oral Surg Oral Med Oral Pathol Oral Radiol Endo 91 (2001) 62-69
20. NCI SEER. http://seer.cancer.gov/csr/1973-1999; 2002, 2004.
21. National Death Index. http://www.cdc.gov/nchs/r&d/ndi/ndi.htm.
22. Kaplan E.L., and Meier P. Nonparametric estimation from incomplete observations. J Amer Stat Assoc 53 (1958) 457-481
23. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50 (1966) 163-170
24. S-PLUS 2000 Academic Site, editor. Version 6.2. Seattle WA: Math Soft, Inc.; 2003.
25. Cox D.R. Regression models and life tables. JR Stat Soc (B) 34 (1972) 187-220
26. Ritchie J.M., Smith E.M., Summersgill K.F., Hoffman H.T., Wang D., Klussmann J.P., et al. Human papillomavirus infection as a prognostic factor in carcinomas of the oral cavity and oropharynx. Int J Cancer 104 (2003) 336-344
27. Allison P.D. Survival analysis using the SAS System, a practical guide (1995), SAS Institute, Inc., Cary, NC
28. SAS System for Windows, version 9.1. Cary, NC: SAS Institute; 2002-2003.
29. INK4a as a complementary marker of high-grade intraepithelial lesions of the uterine cervix. I: Experience with squamous lesions in 189 consecutive cervical biopsies. Pathol 37 (2005) 112-124
30. Gillison M.L., Koch W.M., Capone R.B., Spafford M., Westra W.H., Wu L., et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst 92 (2000) 709-720
31. Li W., Thompson C.H., Cossart Y.E., O'Brien C.J., McNeil E.B., Scolyer R.A., et al. The expression of key cell cycle markers and presence of human papillomavirus in squamous cell carcinoma of the tonsil. Head Neck 26 (2004) 1-9
32. INK4a immunohistochemical overexpression in premalignant and malignant oral lesions infected with human papillomavirus. J Histochem Cytochem 51 (2003) 1291-1297
33. Geisler S.A., Olshan A.F., Weissler M.C., Cai J., Funkhouser W.K., Smith J., et al. P16 and p53 protein expression as prognostic indicators of survival and disease recurrence from head and neck cancer. Clin Cancer Res 8 (2002) 3445-3453
34. Lang J.C., Borchers J., Danahey D., Smith S., Stover D.G., Agrawal A., et al. Mutational status of overexpressed p16 in head and neck cancer: evidence for germline mutation of p16/p14arf. Int J Oncol 21 (2002) 401-408
35. Reed A.L., Califano J., Cairns P., Westra W.H., Jones R.M., Koch W., et al. High frequency of p16 (cdkn2/mts-1/) inactivation in head and neck squamous cell carcinoma. Cancer Res 56 (1996) 3630-3633
36. Ambrosch P., Schlott T., Hilmes D., and Ruschenburg I. P16 alterations and retinoblastoma protein expression in squamous cell carcinoma and neighboring dysplasia from the upper aerodigestive tract. Virchows Arch 438 (2001) 343-349